Full-Time

Medical Lead

Vascular Malformations

Updated on 2/6/2025

Relay Therapeutics

Relay Therapeutics

201-500 employees

Biotech company focused on drug discovery

Biotechnology
Healthcare

Mid, Senior

Cambridge, MA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary

You match the following Relay Therapeutics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • You have earned an MD or MD/PhD with rare disease and preferably pediatric experience
  • You know what successful small molecule development looks like and you bring 3+ years of industry experience in early clinical development
  • You have experience in design and execution of innovative clinical trials including design and development of clinical protocols and statistical analysis plans
  • You have outstanding interpersonal and communication skills both written and oral and ability to communicate complex information clearly and succinctly
  • You have excellent leadership skills and proven ability to effectively work in a cross-functional/matrix environment
  • You know how to work collaboratively with experts and leaders across Research, Pharmaceutical Development, Clinical, Regulatory and Strategy & Operations
  • You have an unwavering commitment to help patients who suffer from debilitating diseases.
Responsibilities
  • Lead collaboration with drug discovery teams, translational medicine, clinical operations, Phase 1 investigators and disease-specific experts to design and oversee execution of early clinical development plans that definitively test key translational hypotheses for Relay Tx medicines and establish clinical proof-of-concept as soon as possible after entering human testing.
  • Design and oversee execution of multi-layered clinical development strategies, in compliance with regulatory guidelines, that identify opportunities for breakthrough therapy designation and accelerated approval while identifying subsequent opportunities for label expansion in a science-driven manner.
  • Lead authoring of clinical sections of key documents, including Investigator’s Brochures, IND summary documents, CTAs for initiation of ex-US studies and responses to questions from regulatory authorities, IRBs, and ethics committees.
  • Inform global registration strategy by providing expert medical review, assessment, and interpretation of clinical data and preparing results for presentation to regulatory authorities.
  • Oversee drug safety and pharmacovigilance activities for ongoing trial(s).
  • Rapidly integrate new insights derived from on-going Relay Tx or external clinical trials, translational science or basic science into Relay Tx development plans and clinical trial activities.
  • Create compelling data presentations for external disclosures.
  • Proactively manage communication and build strong collaborative relationships with key stakeholders both internally and externally, including interactions with academic experts, clinical trial investigators, and other clinical stakeholders.
  • Ensure Relay Tx maintains the highest standards of compliance and ethical behavior in the design, conduct, interpretation and communication of clinical trials, clinical trial data, and clinical trial results.
Desired Qualifications
  • Ideal applicants have demonstrated success in a fast-paced small biotechnology company setting.

Relay Therapeutics focuses on drug discovery by emphasizing the movement of proteins in its research. The company uses its Dynamo™ platform, which integrates experimental and computational methods, to identify and develop new drugs, particularly for complex diseases that are hard to treat with current therapies. This platform enables Relay to target proteins that have previously been difficult to address, expanding treatment options in areas like precision oncology and genetic diseases. Unlike its competitors, Relay Therapeutics collaborates with major biotech firms, such as Genentech, to validate its technology and generate revenue through licensing and partnerships. The main goal of Relay Therapeutics is to create effective medicines that can significantly improve patients' lives, and it is actively conducting clinical trials to ensure the safety and effectiveness of its drug candidates.

Company Stage

IPO

Total Funding

$535M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery complements Relay's computational techniques, enhancing drug development.
  • Quantum computing integration could boost Dynamo's capabilities in drug discovery.
  • Rising personalized medicine trend aligns with Relay's precision medicine focus.

What critics are saying

  • Increased competition from VantAI threatens Relay's market position.
  • Layoffs may impact Relay's operational efficiency and research progress.
  • Reliance on public offerings suggests potential financial instability for Relay.

What makes Relay Therapeutics unique

  • Relay's Dynamo platform targets previously undruggable proteins, expanding treatment possibilities.
  • Focus on protein motion places Relay at the forefront of innovative drug discovery.
  • Relay's precision oncology approach tailors treatments to individual genetic profiles.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, vision

Life, disability, & FSA

401k

Commuter benefits

Parental leave

Home office stipend

Tuition reimbursement

PTO